Pablo Spaletra2014-12-06Servicio de Cardiología Intervencionista y Terapias EndovascularesInstituto Cardiovascular de Buenos AiresBuenos Aires, Argentina
Pablo Spaletra2014-12-06Servicio de Cardiología Intervencionista y Terapias EndovascularesInstituto Cardiovascular de Buenos AiresBuenos Aires, Argentina
Pablo Spaletra2014-12-06Servicio de Cardiología Intervencionista y Terapias EndovascularesInstituto Cardiovascular de Buenos AiresBuenos Aires, Argentina
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....
Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG). However, many of...
